Related Experiment Video
Updated: Jun 24, 2025
08:02
Cell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
Published on: November 7, 2013
12.9K
Programmable DNA Scaffolds Enable Orthogonal Engineering of Cell Membrane-Based Nanovesicles for Therapeutic
Wei Li1, Shuyun Liu2, Zhenghao Wang1,3
1Department of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, West China Hospital, Sichuan University, Chengdu 610041, China.
Nano Letters
|June 10, 2024
Summary
Researchers developed a DNA scaffold method for precise cell membrane-based nanovesicle (CMNV) surface engineering. This approach enables controlled display of multiple ligands for enhanced theranostic applications.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Molecular Biology
Background:
- Cell membrane-based nanovesicles (CMNVs) are crucial for biological transport and promising for theranostics.
- Current CMNV surface engineering lacks flexibility and orthogonality for precise multi-ligand display.
Purpose of the Study:
- To develop a novel DNA scaffold-programmed approach for orthogonal surface engineering of CMNVs.
- To enable precise and flexible display of multiple ligands on CMNVs for advanced applications.
Main Methods:
- Designed DNA scaffolds that rapidly anchor to CMNV surfaces.
- Utilized unique DNA sequences and hybridization properties for independent control of biomolecule loading.
- Engineered CMNVs with a renal-targeting peptide and a therapeutic protein.
Main Results:
- Achieved orthogonal and controlled loading of multiple ligands onto CMNVs.
- Demonstrated enhanced renal targeting and repair potential in vivo using engineered CMNVs.
- Validated the DNA scaffold platform for versatile CMNV surface modification.
Conclusions:
- The DNA scaffold-programmed platform offers a flexible and potent method for orthogonal CMNV surface engineering.
- This approach facilitates the development of CMNV-based theranostic agents with tailored functionalities.
- Opens new avenues for designing advanced nanomaterials for targeted therapies.
